Wei Fen, Wang Sicen, Gou Xilan
Health Science Center, School of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.
Biophys Rep. 2021 Dec 31;7(6):504-516. doi: 10.52601/bpr.2021.210042.
With the biological relevance of the whole cells, low cost compared with animal experiments, a wide variety of cell-based screening platforms (cell-based assay, cell-based microfluidics, cell-based biosensor, cell-based chromatography) have been developed to address the challenges of drug discovery. In this review, we conclude the current advances in cell-based screening and summary the pros and cons of the platforms for different applications. Challenges and improvement strategies associated with cell-based methods are also discussed.
鉴于全细胞的生物学相关性、与动物实验相比成本较低,已开发出多种基于细胞的筛选平台(基于细胞的检测、基于细胞的微流控技术、基于细胞的生物传感器、基于细胞的色谱法)来应对药物发现的挑战。在本综述中,我们总结了基于细胞筛选的当前进展,并概述了这些平台在不同应用中的优缺点。还讨论了与基于细胞方法相关的挑战和改进策略。